Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

John Hudson

Sleep Medicine Austin, TX Medical Doctor

NPI 1487626008 CMS profile 21316

5508 Parkcrest Dr, Suite 310, Austin, TX 78731

Open in the dashboard

General payments

$16,435

255 records reported · program years 2019–2024

Research payments

$98,387

Paid to them · 23 records reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$10,388,488 paid to institutions, not to them · program years 2019–2025

Through program year 2024, John Hudson of Austin, TX is reported in the CMS Open Payments database as having received $16,435 across 255 general payments and $98,387 in research payments paid to them. Separately, studies naming them as principal investigator received $10,388,488 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Sleep Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

9 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $133 2
2024 Research $19,052 3
2023 General $3,797 42
2023 Research $70,171 15
2022 General $926 49
2022 Research $9,164 5
2021 General $842 58
2020 General $4,141 37
2019 General $6,596 67

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • John Hudson
  • Sleep Medicine median
  • Middle half of Sleep Medicine
  • National median

In program year 2025, general payments to John Hudson were reported at $0. Among 263 Sleep Medicine profiles paid that year, the median was $337 and the middle half received between $114 and $1,241.

Show as a table
Year John Hudson Sleep Medicine median Middle half National median
2019 $6,596 $206 $79–$855 $163
2020 $4,141 $170 $48–$1,437 $114
2021 $842 $178 $53–$1,297 $132
2022 $926 $313 $95–$1,332 $149
2023 $3,797 $307 $117–$1,081 $160
2024 $133 $308 $100–$1,432 $164
2025 $0 $337 $114–$1,241 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Jazz Pharmaceuticals Inc. $8,172 63 payments
  2. Harmony Biosciences LLC $2,240 77 payments
  3. Biogen, Inc. $1,599 11 payments
  4. Genentech USA, Inc. $1,393 5 payments
  5. Merck Sharp & Dohme Corporation $1,076 34 payments
  6. Eisai Inc. $690 9 payments
  7. Sage Therapeutics, Inc. $325 5 payments
  8. Teva Pharmaceuticals USA, Inc. $174 5 payments
  9. Arbor Pharmaceuticals, Inc. $160 11 payments
  10. Takeda Pharmaceuticals U.S.A., Inc. $158 9 payments
  11. Other $450 26 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Consulting Fee $7,450 3 payments
  2. Food and Beverage $5,083 234 payments
  3. Travel and Lodging $3,856 17 payments
  4. Education $45 1 payment
Products named General payments · program years 2019–2024
  1. SUNOSI Pain $4,456 13 payments
  2. SUNOSI Neurology $2,712 19 payments
  3. Wakix Neurological Disorders $2,047 68 payments
  4. XYWAV $701 18 payments
  5. BELSOMRA $261 26 payments
  6. XYREM $247 10 payments
  7. WAKIX Sleep Medicine $192 9 payments
  8. RYLAZE $186 7 payments
  9. VYVANSE $182 10 payments
  10. Ajovy $174 5 payments
  11. Other $633 39 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2024
  1. Eli Lilly and Company $56,472 15 payments
  2. Pfizer Inc. $41,916 8 payments

Records

278 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Sleep Medicine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record